Phacilitate Cell & Gene Therapy Forum 2010

Building on the resounding success of the last 5 Cell & Gene Therapy Forums, the 2010 event will once again provide a highly valuable meeting place for senior level figures driving the transition of these technologies into safe-commercially-viable products. The 3 day conference program will feature a mixture of business, regulatory and scientific topics, with speakers drawn from big pharma/biotech, the regulators and cell and gene therapy developers themselves. Breakout sessions, workshops and panel discussions combine to make the event highly interactive. In 2010, the Cell & Gene Therapy Forum will once again run concurrently with Phacilitates annual North American Vaccine Forum. Participants will be able to select the conference agenda of greatest current value to themselves and their organization, with all networking opportunities shared between the two events. Breakfast and lunch buffets, extended refreshment breaks and evening receptions will all take place in the shared exhibition area. A total of 500+ senior level attendees participated in 2009. For more information on how your company can raise its profile with both sets of attendees all under one roof and in just three days at the 10 event. Typically, over 80% of participants represent cell/gene therapy and vaccine developers themselves, and are at Director level and above. Typical titles are -CEOs, COOs, Presidents, Managing Directors & Board Members -Vice Presidents and Directors of Licensing, Business Development, Corporate Development, and Strategy & Planning -CSOs and Vice Presidents and Directors of R&D, Research, Development, Preclinical Research, Clinical Research, Project Management and Product Development -Vice Presidents and Directors of Manufacturing, Process Development and Technical Development -Vice Presidents, Directors and Senior Managers of Regulatory Affairs, Government Affairs and Public Affairs The remaining 20% of participants are high-level representatives of -Key government bodies -NGOs -Analysts, VCs and other investors Please contact Nicola McCall for sponsorship and exhibiting information.